Are you Dr. Pittman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 50 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2 Wramc Department
6900 Georgia Ave Nw
Washington, DC 20307Phone+1 301-619-2997Fax+1 301-619-1317
Summary
- Dr. Phillip Pittman, MD is a board certified internist in Washington, District of Columbia. He is currently licensed to practice medicine in Maryland.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1977 - 1980
Harvard Medical SchoolClass of 1977
Certifications & Licensure
MD State Medical License 1984 - 2025- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Safety/Immunogenicity/Genetic Drift of MP-12 Rift Valley Fever Vaccine Start of enrollment: 2006 Aug 01
Publications & Presentations
PubMed
- 21 citationsPotent neutralization of Rift Valley fever virus by human monoclonal antibodies through fusion inhibition.Nathaniel S. Chapman, Haiyan Zhao, Nurgun Kose, Jonna B. Westover, Birte Kalveram
Proceedings of the National Academy of Sciences of the United States of America. 2021-04-06 - 99 citationsImmunogenicity of an inactivated Rift Valley fever vaccine in humans : a 12-year experiencePhillip R. Pittman, Ching-Tong Liu, Timothy L. Cannon, Richard S. Makuch, Joseph A. Mangiafico
Vaccine. 1999-08-20 - 20 citationsTh17 cytokines in recall responses against Francisella tularensis in humans.Chrysanthi Paranavitana, Elzbieta Zelazowska, Luis DaSilva, Phillip R. Pittman, Mikeljon P. Nikolich
Journal of Interferon & Cytokine Research. 2010-09-21
Press Mentions
Phase 3 Results of Bavarian Nordics Smallpox Vaccine Published in the New England Journal of MedicineNovember 14th, 2019
New Smallpox Vaccine Tested by USAMRIID Receives FDA ApprovalSeptember 30th, 2019
